bibliographicCitation |
Dichtl S, Zaderer V, Kozubowski V, Abd El Halim H, Lafon E, Lanser L, Weiss G, Lass-Flörl C, Wilflingseder D, Posch W. Cilgavimab/Tixagevimab as alternative therapeutic approach for BA.2 infections. Front Med (Lausanne). 2022;9():1005589. PMID: 36250084; PMCID: PMC9556863. |